Who Holds GT Biopharma, Inc. (GTBP)? 59 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 59 holders, $966,566 in total.
Largest holders
The 59 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 376,399 | $184,436 | -17% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 266,788 | $130,648 | -9% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 225,938 | $110,710 | +0% | 13F |
| Everhart Financial Group, Inc. | 100,000 | $48,970 | New | 13F |
| Arax Advisory Partners | 93,627 | $45,850 | +0% | 13F |
| Opal Wealth Advisors, LLC | 81,811 | $40,063 | New | 13F |
| NORTHERN TRUST CORP | 75,461 | $36,953 | New | 13F |
| ALONGSIDE, LLC | 64,000 | $31,341 | New | 13F |
| 49 WEALTH MANAGEMENT, LLC | 64,000 | $31,341 | New | 13F |
| Cetera Investment Advisers | 55,936 | $27,392 | New | 13F |
| SeaCrest Wealth Management, LLC | 50,100 | $24,534 | +0% | 13F |
| KITCHING PARTNERS, LLC | 50,000 | $24,485 | New | 13F |
| PNC Financial Services Group, Inc. | 40,000 | $19,600 | New | 13F |
| Integrated Wealth Concepts LLC | 40,012 | $19,594 | +100% | 13F |
| OSAIC HOLDINGS, INC. | 38,500 | $18,857 | +83% | 13F |
| LPL Financial LLC | 36,379 | $17,815 | +20% | 13F |
| MORGAN STANLEY | 22,573 | $11,054 | +36% | 13F |
| Keel Point, LLC | 20,768 | $10,170 | +0% | 13F |
| Corient Private Wealth LP | 20,000 | $9,794 | New | 13F |
| Private Wealth Management Group, LLC | 20,000 | $9,794 | +0% | 13F |
| SAGESPRING WEALTH PARTNERS, LLC | 20,000 | $9,794 | New | 13F |
| StoneX Group Inc. | 23,258 | $8,667 | +58% | 13F |
| Caitlin John, LLC | 16,500 | $8,080 | +0% | 13F |
| WELLS FARGO & COMPANY/MN | 15,986 | $7,828 | 0% | 13F |
| Tempus Wealth Planning, LLC | 15,000 | $7,346 | New | 13F |
| TWO SIGMA SECURITIES, LLC | 13,386 | $6,555 | -58% | 13F |
| Prospera Financial Services Inc | 12,500 | $6,121 | +4% | 13F |
| Verdence Capital Advisors LLC | 12,000 | $5,876 | +0% | 13F |
| LaSalle St. Investment Advisors, LLC | 11,000 | $5,387 | +0% | 13F |
| Mayflower Financial Advisors, LLC | 11,000 | $5,387 | New | 13F |
| PARSONS CAPITAL MANAGEMENT INC/RI | 10,900 | $5,338 | +0% | 13F |
| Koss-Olinger Consulting, LLC | 10,000 | $4,897 | New | 13F |
| NORTH STAR ASSET MANAGEMENT INC | 10,000 | $4,896 | New | 13F |
| BlackRock, Inc. | 8,312 | $4,070 | -1% | 13F |
| ROYAL BANK OF CANADA | 7,600 | $4,000 | +5932% | 13F |
| HBK Sorce Advisory LLC | 10,000 | $3,175 | +0% | 13F |
| Atlantic Union Bankshares Corp | 5,351 | $2,620 | New | 13F |
| Allworth Financial LP | 4,501 | $2,205 | +0% | 13F |
| NFSG Corp | 3,750 | $1,836 | +0% | 13F |
| MassMutual Private Wealth & Trust, FSB | 3,000 | $1,469 | +0% | 13F |
| Farther Finance Advisors, LLC | 3,000 | $1,469 | +0% | 13F |
| West Financial Advisors, LLC | 2,500 | $1,225 | +0% | 13F |
| Stone House Investment Management, LLC | 2,043 | $1,000 | +63% | 13F |
| Tower Research Capital LLC (TRC) | 1,696 | $831 | 0% | 13F |
| Triumph Capital Management | 1,655 | $810 | +0% | 13F |
| BARCLAYS PLC | 1,441 | $706 | New | 13F |
| JONES FINANCIAL COMPANIES LLLP | 1,500 | $645 | New | 13F |
| Reyes Financial Architecture, Inc. | 625 | $306 | New | 13F |
| Global Retirement Partners, LLC | 500 | $245 | New | 13F |
| HARBOUR INVESTMENTS, INC. | 500 | $245 | New | 13F |
| HRT FINANCIAL LP | 107,140 | $52 | New | 13F |
| Hilltop National Bank | 100 | $49 | +0% | 13F |
| IFG Advisory, LLC | 33 | $16 | New | 13F |
| Coston, McIsaac & Partners | 17,092 | $8 | +0% | 13F |
| AM INVESTMENT STRATEGIES LLC | 15,000 | $7 | +0% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 6 | $3 | -62% | 13F |
| UBS Group AG | 2 | $1 | -100% | 13F |
| JPMORGAN CHASE & CO | 1 | $0 | +0% | 13F |
| SBI Securities Co., Ltd. | 1 | $0 | +0% | 13F |
Questions and answers
- How many institutions hold GT Biopharma, Inc.?
- 59 managers reported GT Biopharma, Inc. on Form 13F for the quarter ended 30 June 2026, against 42 the quarter before.
- Who is the largest institutional holder of GT Biopharma, Inc.?
- VANGUARD CAPITAL MANAGEMENT LLC, with 376,399 shares worth $184,436 on its 13F for Q2 2026.
- How many institutions bought or sold out of GT Biopharma, Inc. in Q2 2026?
- 22 managers reported a new position and 5 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds GT Biopharma, Inc., Q2 2026", https://app.tamarly.ai/holders/gt-biopharma, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.